Business · 30/11/2018Updated: 10/17/2026 · 1 min read
FDA Announces Draft Guidance for Prescription Blood Glucose Monitoring Systems
Summary
The Food and Drug Administration (FDA) has released a draft guidance document outlining studies and criteria for submitting premarket notifications for prescription blood glucose monitoring systems, which are used to monitor blood glucose levels in patients with diabetes.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →